Standards; Chiral Molecules; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
Carboxylate form of Irinotecan, a DNA topoisomerase inhibitor.
Kunimoto, T., et al.: Cancer Res., 47, 5944 (1987), Shimada, Y., et al.: J. Clin. Oncol., 11, 909 (1993), Chen, A., et al.: Annu. Rev. Pharmacol. Toxicol., 34, 191
400-821-0725
沪ICP备17019645号
